1. Home
  2. LITB vs XLO Comparison

LITB vs XLO Comparison

Compare LITB & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LITB
  • XLO
  • Stock Information
  • Founded
  • LITB 2007
  • XLO 2016
  • Country
  • LITB Singapore
  • XLO United States
  • Employees
  • LITB N/A
  • XLO N/A
  • Industry
  • LITB Catalog/Specialty Distribution
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LITB Consumer Discretionary
  • XLO Health Care
  • Exchange
  • LITB Nasdaq
  • XLO Nasdaq
  • Market Cap
  • LITB 38.0M
  • XLO 35.7M
  • IPO Year
  • LITB N/A
  • XLO 2021
  • Fundamental
  • Price
  • LITB $2.00
  • XLO $0.76
  • Analyst Decision
  • LITB
  • XLO Buy
  • Analyst Count
  • LITB 0
  • XLO 2
  • Target Price
  • LITB N/A
  • XLO $3.00
  • AVG Volume (30 Days)
  • LITB 69.5K
  • XLO 948.8K
  • Earning Date
  • LITB 09-09-2025
  • XLO 11-06-2025
  • Dividend Yield
  • LITB N/A
  • XLO N/A
  • EPS Growth
  • LITB N/A
  • XLO N/A
  • EPS
  • LITB 0.12
  • XLO N/A
  • Revenue
  • LITB $220,656,000.00
  • XLO $15,001,000.00
  • Revenue This Year
  • LITB N/A
  • XLO $519.70
  • Revenue Next Year
  • LITB N/A
  • XLO $44.57
  • P/E Ratio
  • LITB $17.13
  • XLO N/A
  • Revenue Growth
  • LITB N/A
  • XLO 536.45
  • 52 Week Low
  • LITB $0.91
  • XLO $0.62
  • 52 Week High
  • LITB $3.33
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • LITB 67.10
  • XLO 62.46
  • Support Level
  • LITB $2.02
  • XLO $0.71
  • Resistance Level
  • LITB $2.32
  • XLO $0.78
  • Average True Range (ATR)
  • LITB 0.24
  • XLO 0.04
  • MACD
  • LITB 0.05
  • XLO 0.01
  • Stochastic Oscillator
  • LITB 72.17
  • XLO 71.63

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: